0001209191-20-003083.txt : 20200110 0001209191-20-003083.hdr.sgml : 20200110 20200110170015 ACCESSION NUMBER: 0001209191-20-003083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200108 FILED AS OF DATE: 20200110 DATE AS OF CHANGE: 20200110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taylor Stacy L CENTRAL INDEX KEY: 0001799081 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 20521824 MAIL ADDRESS: STREET 1: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION STREET 2: 1551 EASTLAKE AVENUE E SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-08 0 0001478320 Adaptive Biotechnologies Corp ADPT 0001799081 Taylor Stacy L C/O ADAPTIVE BIOTECHNOLOGIES 1551 EASTLAKE AVE E STE 200 SEATTLE WA 98102 0 1 0 0 SVP and General Counsel Common Stock 2020-01-08 4 M 0 662 6.55 A 1962 D Common Stock 2020-01-08 4 S 0 662 30.00 D 1300 D Stock Option (Right to Buy) 6.55 2020-01-08 4 M 0 662 0.00 D 2028-04-24 Common Stock 52662 50000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019. The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. /s/ Stacy L. Taylor by Eric Billings as attorney-in-fact 2020-01-10